Related content

Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients

By Hesse C.J.   Baan C.C.   Balk A.H.M.M.   Metselaar H.J.   Weimar W.   van Gelder T.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2988-2990

Elsevier

Access to resources Recommend Favorite

Evaluation of the tacrolimus Emit ( R) 2000 Dade Behring kit in liver transplant recipients and comparison with the IMx ( R) Tacrolimus II Abbott.kit

By Doyen C.   Revenant M.-C.  

Immunoanalyse & Biologie Specialisee, Vol. 18, Iss. 6, 2003-12 ,pp. : 360-364

Elsevier

Access to resources Recommend Favorite

Conversion from tacrolimus to neoral in liver and kidney transplant recipients

By Ott R.   Bussenius-Kammerer M.   Scholz D.   Neuhaus R.   Tolba R.H.   Fricke L.   Muller V.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3166-3168

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients

By Braun F.   Schutz E.   Peters B.   Talaulicar R.   Grupp C.   Undre N.   Schafer A.   Armstrong V.W.   Oellerich M.   Ringe B.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2127-2128

Elsevier

Access to resources Recommend Favorite

Tacrolimus-induced neurotoxicity in kidney transplant recipients

By Veroux P.   Veroux M.   Puliatti C.   Morale W.   Cappello D.   Valvo M.   Macarone M.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3188-3190

Elsevier

Access to resources Recommend Favorite